JPWO2021092486A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021092486A5 JPWO2021092486A5 JP2022526285A JP2022526285A JPWO2021092486A5 JP WO2021092486 A5 JPWO2021092486 A5 JP WO2021092486A5 JP 2022526285 A JP2022526285 A JP 2022526285A JP 2022526285 A JP2022526285 A JP 2022526285A JP WO2021092486 A5 JPWO2021092486 A5 JP WO2021092486A5
- Authority
- JP
- Japan
- Prior art keywords
- arm
- release rate
- rate controlling
- controlling film
- pdl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962933313P | 2019-11-08 | 2019-11-08 | |
| US62/933,313 | 2019-11-08 | ||
| PCT/US2020/059536 WO2021092486A1 (fr) | 2019-11-08 | 2020-11-06 | Formulations pour films modulant le taux de libération pour systèmes de résidence gastrique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022554383A JP2022554383A (ja) | 2022-12-28 |
| JPWO2021092486A5 true JPWO2021092486A5 (fr) | 2023-11-14 |
Family
ID=75849585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526285A Pending JP2022554383A (ja) | 2019-11-08 | 2020-11-06 | 胃内滞留システムのための放出速度調節フィルム用製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220387310A1 (fr) |
| EP (1) | EP4054642A4 (fr) |
| JP (1) | JP2022554383A (fr) |
| CN (1) | CN114938634A (fr) |
| AU (1) | AU2020378437A1 (fr) |
| CA (1) | CA3160660A1 (fr) |
| WO (1) | WO2021092486A1 (fr) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0214013D0 (en) * | 2002-06-18 | 2002-07-31 | Euro Celtique Sa | Pharmaceutical product |
| US8969415B2 (en) * | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
| US20130273135A1 (en) * | 2008-03-25 | 2013-10-17 | University Of Utah Research Foundation | Controlled Release Combination Biomaterials |
| US20130017264A1 (en) * | 2011-07-15 | 2013-01-17 | Piramal Life Sciences Limited | Alginate tube drug delivery system and method therefor |
| BR112016028957B1 (pt) * | 2014-06-11 | 2021-12-14 | The Brigham And Women's Hospital, Inc. | Estrutura de residência gástrica |
| US20170266112A1 (en) * | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| WO2018064630A1 (fr) * | 2016-09-30 | 2018-04-05 | Lyndra, Inc. | Systèmes de résidence gastrique permettant l'administration prolongée de médicaments de la classe de l'adamantane |
| WO2018102799A1 (fr) * | 2016-12-02 | 2018-06-07 | Clexio Biosciences Ltd. | Système à résidence gastrique |
| CA3066658A1 (fr) * | 2017-06-09 | 2018-12-13 | Lyndra, Inc. | Systemes gastriques a demeure avec films modulant le taux de liberation |
| US11793751B2 (en) * | 2017-09-20 | 2023-10-24 | Lyndra Therapeutics, Inc. | Encapsulation of gastric residence systems |
| US11684315B2 (en) * | 2017-11-28 | 2023-06-27 | Massachusetts Institute Of Technology | Gastric resident electronics |
-
2020
- 2020-11-06 CN CN202080091842.6A patent/CN114938634A/zh active Pending
- 2020-11-06 CA CA3160660A patent/CA3160660A1/fr active Pending
- 2020-11-06 AU AU2020378437A patent/AU2020378437A1/en active Pending
- 2020-11-06 WO PCT/US2020/059536 patent/WO2021092486A1/fr unknown
- 2020-11-06 JP JP2022526285A patent/JP2022554383A/ja active Pending
- 2020-11-06 US US17/774,127 patent/US20220387310A1/en active Pending
- 2020-11-06 EP EP20885040.4A patent/EP4054642A4/fr active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7337746B2 (ja) | 自己集合滞留デバイスおよび関連方法 | |
| US20200146978A1 (en) | Taste-masked pharmaceutical compositions | |
| Bertram et al. | In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form | |
| FI101344B (fi) | Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta | |
| US6878387B1 (en) | Coated medicament forms with controlled active substance release | |
| JP4963767B2 (ja) | 制御放出性製剤の製法 | |
| US6350527B1 (en) | Gels and multilayer surface structures from boronic acid containing polymers | |
| JP2017524662A5 (fr) | ||
| AU2024221711A1 (en) | Gastric residence systems with release rate-modulating films | |
| JP2000051367A5 (fr) | ||
| KR20090065524A (ko) | 프로그래머블 부력전달기술 | |
| JP2010094519A (ja) | 止血用インプラント | |
| NO309360B1 (no) | Stabilisert, fast doseringsform med kontrollert frigivelse av en dose av et terapeutisk aktivt middel og fremgangsmåte for fremstilling av denne | |
| MX2012010648A (es) | Preparacion solida de facil dosificacion. | |
| Chandy et al. | Delivery of LMW heparin via surface coated chitosan/peg-alginate microspheres prevents thrombosis | |
| JPH0624959A (ja) | 胃内浮遊型薬物徐放性固形製剤 | |
| RU2020109657A (ru) | Фармацевтический препарат, содержащий 3-фтор-4-[7-метокси-3-метил-8-(1-метил-1h-пиразол-4-ил)-2-oксo-2,3-дигидро-имидазо[4,5-c]хинолин-1-ил]-бензонитрил | |
| JPWO2021092486A5 (fr) | ||
| KR20120006983A (ko) | 고형 제제 | |
| US5254347A (en) | Controlled release pharmaceutical preparation and method for producing the same | |
| WO2006117803A2 (fr) | Systemes d'administration transmucosale de medicaments | |
| WO2009010238A2 (fr) | Formulations de duloxétine | |
| JPWO2021092491A5 (fr) | ||
| Wagh et al. | Thiomers: a new generation of mucoadhesive polymers | |
| US20220387310A1 (en) | Formulations for release-rate modulating films for gastric residence systems |